Background
Prior to deployment to Afghanistan and Iraq in support of Operations Enduring and Iraqi Freedom (OEF/OIF), US service members report baseline health functioning superior to that of the general US population [
1]. Following deployment, however, veterans report they have poorer health [
2,
3]. In fact, the number of OEF/OIF veterans rating their overall health as fair or poor doubled six months after returning home as compared to their initial post-deployment assessment [
2]. This is concerning because lower self-assessed functional health, particularly in the physical domain, has been associated with both greater health care utilization and mortality in veterans of prior conflicts [
4‐
6] and in community samples [
7,
8].
Although several studies suggest that as time since deployment to OEF/OIF increases so too does the prevalence of poor mental health functioning among US service members, [
2,
9,
10] less attention has been paid to how physical functioning changes over time [
11‐
13]. Importantly, we do not know whether there is a similar trend toward reduced physical function over time since return from deployment from OEF/OIF. Such investigation is especially warranted given that veterans of prior conflicts generally have worse health functioning than the general U.S. population, [
5,
14] with the largest disparity observed in the physical domain [
6]. Moreover, a worsening of physical functioning over time could lead to long term disability and have numerous public health implications (e.g., greater health care utilization and mortality) that would be especially problematic for this relatively young, working age population.
Therefore, the purpose of this study is to examine physical health in OEF/OIF veterans as a function of time since deployment using data from OEF/OIF veterans seen in a post-deployment health clinic. We also examined data from a military community sample as a comparison group to enhance generalizability. This sample participated in a longitudinal, prospective cohort study of OEF/OIF veterans who were followed from pre-deployment to one year after return from deployment. Because of the strong link between Posttraumatic Stress Disorder (PTSD) and health as well as its high prevalence among OEF/OIF veterans [
15,
16], we included PTSD in our analysis predicting post-deployment health functioning. Additionally, using data from both clinical (i.e., treatment-seeking) and community samples afforded us the ability to address the concern that our findings were specific only to a treatment-seeking sample. Moreover, if we were to find similar effects across these two different samples, it would suggest a more generalizable impact of military service and thus better inform the public health community.
Methods
Study design, sample and data extraction (cross-sectional clinical sample)
Data from 679 OEF/OIF veterans clinically evaluated (June 2004 – October 2010) at a post-deployment health clinic (New Jersey War Related Illness and Injury Study Center) were examined retrospectively with approval from the Institutional Review Board at the VA New Jersey Healthcare System and in accordance with the Helsinki Declaration. We stratified our sample into groups by time post-deployment which was computed as the difference between the veterans’ clinical evaluation date and return from deployment date. This resulted in the following four groups: (1Yr) 0 – 365 days; (2Yr) 366 – 730 days; (3Yr) 731 – 1095 days; and (4Yr+) > 1095 days. Distribution by gender was similar between groups with women accounting for approximately 14% of the total sample (See Table
1 for demographic characteristics).
Table 1
Demographic characteristics of cross-sectional clinical veteran sample
Gender (%)
| | | | | |
F = Female
| F: 13.0% | F: 12.9% | F: 12.3% | F: 16.6% | F: 10.8% |
M = Male
| M: 87.0% | M: 87.1% | M: 87.7% | M: 83.4% | M: 89.2% |
Age (mean ± SD)
| 32.5±9.8 | 32.0±9.6 | 32.0±10.3 | 34.8±9.7 | 28.0±8.3 |
Military Component (%)
| | | | | |
Active Duty | 25.3% | 42.9% | 54.4% | 48.4% | - |
Reserve/National Guard | 74.7% | 57.1% | 45.6% | 51.6% | 100% |
Military Branch (%)
| | | | | |
Navy | 6.3% | 5.5% | 8.5% | 13.4% | - |
Air Force | 1.6% | 4.3% | 5.7% | 10.8% | - |
Marine Corps | 15.8% | 24.5% | 29.2% | 17.8% | - |
Army | 75.9% | 65.6% | 55.7% | 56.7% | 100% |
Coast Guard | - | - | - | 1.3% | - |
Probable PTSD (%)
| 29.8% | 31.3% | 45.8% | 46.6% | - |
Physical Component Summary score
| 46.5±9.6 | 45.9±10.9 | 44.5±9.1 | 42.3±11.8 | Pre: 55.5±5.2 |
| | | | | 0 Post: 53.2±7.3 |
| | | | | 1yr Post: 52.2±8.6 |
Physical Function subscale
| 46.5±10.1 | 45.6±10.7 | 43.9±10.2 | 41.8±11.8 | Pre: 52.4±7.4 |
| | | | | 0 Post: 49.4±8.3 |
| | | | | 1 yr Post: 48.5±9.8 |
Role Physical subscale
| 45.8±10.8 | 45.3±12.2 | 41.1±12.9 | 40.2±13.1 | Pre: 54.6±7.3 |
| | | | | 0 Post: 50.3±9.1 |
| | | | | 1 yr Post: 49.6±9.8 |
Bodily Pain subscale
| 42.4±10.8 | 42.5±11.5 | 41.1±11.2 | 38.8±11.1 | Pre: 55.3±3.9 |
| | | | | 0 Post: 53.3±6.7 |
| | | | | 1 yr Post: 51.8±8.9 |
General Health subscale
| 43.2±10.7 | 41.9±11.1 | 39.7±10.4 | 38.7±11.9 | Pre: 53.2±5.9 |
| | | | | 0 Post: 52.4±6.8 |
| | | | | 1 yr Post: 50.5±9.2 |
Veterans clinically evaluated at our post-deployment health clinic typically come for a one-time comprehensive medical evaluation, during which they complete an intake packet which is entered into a database for scoring and evaluation. We abstracted from the veterans’ clinical evaluation records the following information: demographics, deployment dates, probable diagnosis of PTSD and responses on the Veterans version of the Short Form 36 Health Survey (known as the Veterans RAND or VR-36).
Comparison group (longitudinal military community sample)
To address the concern that our findings were specific to a clinical sample with data from only one time point, PCS scores from our clinical sample were compared to a sample of 768 healthy Army National Guard and Reserve enlisted soldiers (11% female) who deployed to OEF/OIF and were evaluated pre-deployment and up to 1 year post deployment. PCS scores were available for pre-deployment, immediate post-deployment and approximately one year (+/− 4 months) after return from deployment. All participants provided informed consent and study procedures were approved by three institutional review boards (VA New Jersey Healthcare System, G.V. (Sonny) Montgomery VA Medical Center, and the Walter Reed Army Medical Center Department of Clinical Investigation).
Measured variables
For both samples we had the same measures of physical function and PTSD symptoms. From the VR-36, we computed the PCS score to provide an overall measure of physical health-related functioning which was the primary outcome variable. PCS scores are standardized from published results of the US population to a mean of 50 and standard deviation of 10, with higher scores reflecting better health [
17‐
20]. To assess which facets of physical function were most important to overall physical function in this sample, we also assessed four subscales that contribute to the PCS: physical functioning (i.e., the presence and extent of physical limitations), role-physical (i.e., the extent to which one can physically engage in their work or other activities), bodily pain (i.e., intensity and impact of pain) and general health (i.e., rating of health) [
21‐
23].
The Posttraumatic Stress Disorder Checklist-Civilian version (PCL-C) was used to indicate the presence of posttraumatic stress symptoms. The 17 items of the checklist correspond to the diagnostic symptoms of PTSD and the measure demonstrates good psychometric properties in veterans when a score of 50 or more is used to define likely presence of PTSD [
24]. For consistency with prior reports from the OEF/OIF population, [
25] we chose to additionally require that the Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria of one intrusion (e.g., recurrent and distressing recollections, flashbacks or dreams about the event), three avoidance (e.g., emotional numbing, avoiding reminders, amnesia for the event) and two hyperarousal symptoms (e.g., hypervigilance, hyperstartle, concentration problems) were also present at the “moderately” or higher level. These two requirements (e.g., PCL-C ≥ 50 and DSM IV criteria) were used to define probable PTSD.
Statistical analysis
For our clinical sample, the PCS and the four physical health subscales of the VR-36 were analyzed separately via ANCOVA (covariates of probable PTSD, age, gender, and the combination of PTSD, age and gender) with planned linear polynomial contrasts to assess the effect of time between return from deployment and visit to our clinic. Rates of probable PTSD, age and gender were compared between groups using a chi-square test or one-way ANOVA with Tukey post-hoc comparisons, respectively. A 5% alpha level (two-tailed) was considered statistically significant.
For our longitudinal military community sample, PCS scores were compared using a mixed model analysis. To handle missing data, we applied the method of multiple imputation [
26]. Per Graham [
27,
28], we created 40 imputed datasets using IVEWare [
29] and imputed results were combined using SAS MIANALYZE procedure (SAS v9.1). Demographic variables, including education (as a proxy for socioeconomic status), age and gender, as well as data pertaining to PCS variables collected at all waves were used to generate the imputed datasets. However, multiple imputation was not performed for the clinical sample where less than 2.5% of data were missing for any variable of interest. Bonferonni correction was applied for multiple tests at a 5% alpha level (one-tailed).
Discussion
Veterans evaluated at our post-deployment health clinic endorsed physical health-related functioning that is substantially worse than that of the general US population (Figure
1) and indicative of impaired physical functioning irrespective of time post-deployment (Figure
2). However, for those in our clinical sample the longer after the return from deployment that the veteran attended the clinic, the worse his/her physical function. PCS scores remained low (i.e., poor physical function) even after accounting for comorbidity with probable PTSD, suggesting that physical health-related functioning may be an important problem regardless of PTSD status. Similarly, two subscales that comprise the PCS score (i.e., physical functioning and role-physical functioning) also indicated that the longer after return from deployment that Veterans were seen in our clinic, the lower their physical health even with adjustment for PTSD, age and gender. Together these findings suggest that given the average age of our sample (i.e., 32 years), it is critically important to plan carefully for what could be substantial, and long-term future health care needs for this cohort of veterans.
A potential limitation of the cross-sectional clinical sample is that PCS scores indicating poor physical function may simply mean that veterans wait to be seen at our post-deployment health clinic until they are sufficiently symptomatic. Since we do not have pre- or early post-deployment data on this clinical sample it is impossible to say if the service members have worsened over time, if their condition has always been poor, or if those who were seen further from their deployment date simply had a higher threshold for seeking care in the face of symptoms. However, the PCS scores in our military community sample of individuals deploying to OEF/OIF obtained before, immediately after and about one-year post-deployment also demonstrated a decrease in PCS scores over time with lower scores post-deployment than pre-deployment despite the fact that the latest post-deployment data was obtained only one year after return (Figure
1). Additionally, we could confirm that on average, this sample was physically healthier than the general US population before deploying. Although a decrease in PCS scores from pre-deployment to immediately post-deployment may be expected due to the physical rigors of the deployment, it is concerning that physical function not only did not improve by 1 year post-deployment, but continued to decline. In fact, PCS scores obtained at 1-year were significantly lower than those obtained immediately post-deployment. Because PCL scores were not available for all time points in this longitudinal sample, we did not control for PTSD in this analysis. Regardless of the factors that may be affecting physical health functioning, such as the presence of probable PTSD, when compared to pre-deployment, PCS scores of veterans one year after deployment were more than three points lower, a difference that in prior literature has been considered clinically significant [
23]. Equally concerning is that from immediately afterdeployment to the one year follow-up, these individuals (mean age = 28 years) demonstrated an approximately 0.9 point decrease in PCS. Thus, even in a military community sample group of veterans over just the first year after return we observed a decrease in physical function from pre- to one-year post-deployment (i.e., over approximately 2 years) that appears to be declining at a faster rate than normal aging. For example, this magnitude of decline is equivalent to approximately half the decrease seen in population norms from the mid-thirties to mid-forties [
23]. That a decline in physical health-related functioning is also present in a military community sample reinforces our observations in those veterans seeking treatment and illustrates a potential robust trend towards declining physical health in OEF/OIF veterans.
In our clinical sample, the longer the duration between return from deployment and their visit to our clinic, the worse the Veteran’s physical health. Irrespective of the length between return from deployment and visit to our clinic, their rating of physical health is worse than that of the general U.S. population (Figure
1). Moreover, veterans 4 Yr+ after a combat deployment report physical health that is worse than individuals with hypertension or liver disease, and their PCS scores begin to approach those of individuals with more severe chronic diseases (Figure
2) [
23]. This is alarming given that PCS scores from over 77,000 service members in the Millennium Cohort Study exceeded the US general population norm (95% CI: 53.3 – 53.4) [
1] as did the PCS scores from our longitudinal military community sample at pre-deployment (Figure
1). Further, previous work in veteran and non-veteran community samples, even for those who are middle aged (i.e., Miilunpalo et al. [
8]), has found that decreases in physical function (PCS) are related to increased risk of both hospitalization and mortality. For example, in a sample of mostly older veterans, a 10-point decrease in PCS in veterans is associated with an age-adjusted 1.4 – 1.8 fold increased risk of hospitalization and a 2.0 – 2.6 fold increased risk of mortality [
15,
30]. A decrement of 5 – 10 points significantly increased the risk of hospitalization (OR 1.13) and mortality (OR 1.14) [
30]. Considering that we found decrements in PCS ranging from 0.9 (immediately post to one-year) in our longitudinal military community sample and 4.2 (1 Yr to 4 yr+) in our cross-sectional sample, it suggests that continued declines like this in these relatively young veterans could confer a future increased risk of hospitalization and mortality. These preliminary data highlight the need for further longitudinal work beyond one-year post-deployment to determine the extent and mechanisms underlying declines in physical function in veterans seeking and not seeking care.
A strength of this study was our ability to compare data from our cross-sectional clinical sample to data from a longitudinal study of community military personnel. We were however, not able to control for PTSD in the community sample. Additionally, we were limited by only having self-report data and not assessing factors contributing to poorer physical health post-deployment such as physical ailments or injuries of particular relevance to this cohort of veterans, e.g. respiratory-related illnesses and mild traumatic brain injury. Future studies should continue to explore factors that contribute to declining physical function after deployment.
Acknowledgements
This study was supported by VA HSR&D IIR 02–296 (to Karen Quigley, PhD) with additional support from the New Jersey War Related Illness and Injury Study Center (Gudrun Lange, PhD, Director), the East Orange Research Enhancement Award Program (Len Pogach, MD, Director) and the Department of Defense Deployment Health Clinical Center (Charles C. Engel, MD, Director). This material is also the result of work supported with resources and the use of facilities at the VA New Jersey Health Care System. We also gratefully acknowledge the efforts of Pauline McManus, RN, Melissa Blatt, MSN, Liliana Almeida, MS, and the HEROES Team in the collection and preparation of data. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All investigators report no conflicts of interest and contributed to the study concept and provided critical revisions to the manuscript. MF, JS, and KQ drafted the manuscript and performed the background literature search. Data analyses were performed by MF and SL, with input from all investigators, and data were provided by KQ, HC, and LM. All authors read and approved the final manuscript.